Professor Alan Boyd is an internationally renowned expert in medicines development, particularly in cell and gene therapy, which many regard as the ultimate medical intervention as it enables doctors to correct a faulty gene in someone born with a defective one. He is using his influence to help the UK regain its former global pre-eminence in life sciences and pharmaceutical medicine development, by applying his extensive life sciences and business experience. He is the founder and CEO of Boyd Consultants, one of the world’s first dedicated gene therapy companies –which has just celebrated its 20th anniversary, Professor Boyd founded the business in 2005 to support the translation of early-stage scientific concepts into viable medicinal products and treatments.
He has since spearheaded the exploration of gene-based medicines and developed the world’s first gene therapy treatment submitted for regulatory approval. It is no exaggeration to say that he led the creation of the Pharmaceutical Medicine specialty and has been involved in bringing more than 20 prescription products to market across many therapeutic areas, including cell and gene therapy. With Boyd Consultants he has built a multi-million-pound, Queen’s Award for Enterprise-winning business with offices and life-science clients worldwide.